HLA-B gene participates in the NF-kappaB signal pathway partly by regulating S100A8 in the laryngeal carcinoma cell line Hep2.

Abstract:

:Human leukocyte antigen B (HLA-B), a novel member of the NF-kappaB signal pathway in laryngeal squamous cell carcinoma (LSCC), mediates immunological surveillance of tumor cells by presenting peptides to cytotoxic T-lymphocytes (CTLs) together with S100 calcium binding protein A8 (S100A8). The objective of this study was to investigate the molecular mechanism of HLA-B and S100A8 in laryngeal carcinogenesis. Flow cytometry, 3-(4,5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay and cell invasion in vitro were used to detect the biological effect of the Hep2 cell line induced by HLA-B RNA interference. RT-PCR and Western blotting were applied to evaluate the expression level of the S100A8 gene after HLA-B RNA interference. Our results showed that HLA-B had negative effects on Hep2 cells by inhibiting apoptosis and cell invasion while decreasing cell proliferation. Additionally, the expression level of HLA-B and S100A8 in LSCC were down-regulated after HLA-B RNA interference. The abnormal expression of HLA-B is thus relevant to the biological effect of laryngeal carcinoma and participates in the NF-kappaB signal pathway partly by regulating the expression of the S100A8 gene.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Guo Y,Liu J,Xu Z,Sun K,Fu W

subject

Has Abstract

pub_date

2008-06-01 00:00:00

pages

1453-9

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

19

pub_type

杂志文章
  • Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2.

    abstract::High mobility group box-B1 (HMGB1), an autophagy activator, is crucial in tumorigenesis. However, its extracellular role and signaling in gastric cancer remain unclear. Samples were collected from gastric cancer patients and healthy controls. Immunohistochemistry and immunocytochemistry were used to determine the loca...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3782

    authors: Zhang QY,Wu LQ,Zhang T,Han YF,Lin X

    更新日期:2015-04-01 00:00:00

  • Metastasis-associated protein 1 inhibits p53-induced apoptosis.

    abstract::Metastasis-associated protein 1 (MTA1) is highly upregulated in cancer cells with metastatic potential; however, the molecular mechanism by which MTA1 increases the metastatic potential of cancer cells is far from clear. We characterized the functional consequences of MTA1 overexpression on p53-induced apoptosis of ca...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Moon HE,Cheon H,Lee MS

    更新日期:2007-11-01 00:00:00

  • ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.

    abstract::Zinc finger protein 703 (ZNF703), identified as an oncogene in luminal B breast cancer, is a member of the NET/NlZ family of zinc finger transcription factors. However, the role of ZNF703 in colorectal cancer (CRC) is unknown. We investigated the expression of ZNF703 in paired tumor and corresponding normal tissues us...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3313

    authors: Ma F,Bi L,Yang G,Zhang M,Liu C,Zhao Y,Wang Y,Wang J,Bai Y,Zhang Y

    更新日期:2014-09-01 00:00:00

  • The relationship between 5-fluorouracil sensitivity and single nucleotide polymorphisms of the orotate phosphoribosyl transferase gene in colorectal cancer.

    abstract::Orotate phosphoribosyl transferase (OPRT) is an enzyme playing an important role in exertion of the effect of 5-fluorouracil (5-FU). A type of gene polymorphism, single nucleotide polymorphism (SNP), is considered to be a factor affecting individual differences in exertion of drug effects, and its analysis has recentl...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kitajima M,Takita N,Hata M,Maeda T,Sakamoto K,Kamano T,Ochiai T

    更新日期:2006-01-01 00:00:00

  • Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.

    abstract::Lapatinib, an inhibitor of human epidermal growth factor receptor 2 (HER2) phosphorylation, has been reported to inhibit several types of tumors such as HER2-overexpressing breast cancer. However, the effect of lapatinib on the malignant phenotype of human osteosarcoma (OS) cells and the potential molecular mechanisms...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2825

    authors: Long XH,Zhang GM,Peng AF,Luo QF,Zhang L,Wen HC,Zhou RP,Gao S,Zhou Y,Liu ZL

    更新日期:2014-01-01 00:00:00

  • Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.

    abstract::Tanshinone IIA (Tan‑IIA; C19H18O3) is derived from Danshen (the roots of Salvia miltiorrhiza), and has been reported to possess anti‑inflammatory and antioxidant activities. Tan‑IIA can inhibit BxPC‑3 human pancreatic cancer cells in vitro through inducing endoplasmic reticulum stress and apoptosis via mitochondrial p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6670

    authors: Su CC

    更新日期:2018-11-01 00:00:00

  • Significant role of macrophages in human cancers associated with Epstein-Barr virus (Review).

    abstract::Epstein-Barr virus (EBV) is a ubiquitous pathogen that was first identified as a human cancer virus. Many human cancers are associated with EBV, and we demonstrated that EBV infects macrophages. Macrophages infected with EBV show a close correlation with many human cancers, and thus more attention must be given to the...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2014.3475

    authors: Shimakage M

    更新日期:2014-11-01 00:00:00

  • Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review).

    abstract::Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed cancer worldwide. It has poor clinical outcome due to intrinsic or acquired drug resistance. Deregulation of both apoptosis and autophagy contributes to chemotherapy resistance and disease progression. A new member of the inhibitors of ...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2019.7082

    authors: Frassanito MA,Saltarella I,Vinella A,Muzio LL,Pannone G,Fumarulo R,Vacca A,Mariggiò MA

    更新日期:2019-05-01 00:00:00

  • B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice.

    abstract::B7-H1 is a co-inhibitory molecule belonging to the B7 family. The B7-H1 protein is only expressed on macrophage lineage of cells in normal tissues, but is overexpressed in most types of tumor. The aberrant expression of cell surface B7-H1 on cancer cells is generally associated with high-risk prognostic factors. The t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2686

    authors: Zhang C,Wang W,Qin X,Xu Y,Huang T,Hao Q,Li W,Wu S,Zhang Y

    更新日期:2013-11-01 00:00:00

  • NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.

    abstract::Never in mitosis gene-A (NIMA)-related expressed kinase 2 (NEK2) has been recently reported to play a role in tumor progression, drug resistance and tumorigenesis. However, little is known about the effects of NEK2 in hepatocellular carcinoma (HCC) metastasis and the underlying mechanism. NEK2 expression levels were e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6224

    authors: Zhang Y,Wang W,Wang Y,Huang X,Zhang Z,Chen B,Xie W,Li S,Shen S,Peng B

    更新日期:2018-03-01 00:00:00

  • Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect?

    abstract::Glioblastoma multiforme (GBM) is the most aggressive human brain cancer. Little is known regarding how these cells adapt to the harsh tumor microenvironment, and consequently survive and resist various treatments. Myoglobin (MB), the oxygen‑binding hemoprotein, has been shown to be ectopically expressed in different h...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7479

    authors: El-Tohamy R,Elkholi I,Elsherbiny ME,Magdy M,Hammam O,Allalunis-Turner J,Emara M

    更新日期:2020-03-01 00:00:00

  • Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.

    abstract::Progestin and adipoQ receptor family member III (PAQR3) is a regulator that negatively modulates the Ras/Raf/MEK/ERK signaling cascade and the GPCR Gβγ subunit signaling pathway. The role of PAQR3 in hepatocellular carcinoma (HCC) has not been elucidated. The present study investigated the expression of PAQR3 and its ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3532

    authors: Wu HG,Zhang WJ,Ding Q,Peng G,Zou ZW,Liu T,Cao RB,Fei SJ,Li PC,Yang KY,Hu JL,Dai XF,Wu G,Li PD

    更新日期:2014-12-01 00:00:00

  • AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity.

    abstract::A-kinase can inhibit RhoA activation through phosphorylating ser188 of RhoA. AKAP is a novel protein that can target PKA to different subcellular compartment. Evidence has been presented that PKA anchorage by AKAP is important for the kinase to exert its function. This study analyzed the role of PKA anchorage in PKA-i...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Wang Y,Chen Y,Chen M,Xu W

    更新日期:2006-10-01 00:00:00

  • Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1.

    abstract::Statins are the most effective drugs used in the reduction of intracellular synthesis of cholesterol. Numerous studies have confirmed that statins reduce the risk of multiple types of cancers. Statin use in cancer patients is associated with reduced cancer-related mortality. Epithelial-to-mesenchymal transition (EMT),...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4897

    authors: Fan Z,Jiang H,Wang Z,Qu J

    更新日期:2016-08-01 00:00:00

  • Association of annexin A2 with cancer development (Review).

    abstract::Annexin A2 (ANXA2) is a well-known calcium-dependent phospholipid binding protein widely distributed in the nucleus, cytoplasm and extracellular surface of various eukaryotic cells. It has been recognized as a pleiotropic protein affecting a wide range of molecular and cellular processes. Dysregulation and abnormal ex...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2015.3837

    authors: Xu XH,Pan W,Kang LH,Feng H,Song YQ

    更新日期:2015-05-01 00:00:00

  • Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.

    abstract::The lipogenic enzyme fatty acid synthase (FAS) is differentially overexpressed and hyperactivated in a biologically aggressive subset of breast carcinomas and minimally in most normal adult tissues, rendering it an interesting target for anti-neoplastic therapy development. Current trends in the treatment of human bre...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Menendez JA,Colomer R,Lupu R

    更新日期:2004-08-01 00:00:00

  • Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.

    abstract::The clinical applications of Rhizoma paridis in traditional Chinese medicine are well known. However, the therapeutic potential of Rhizoma paridis and its active component such as Paris saponin I (polyphyllin D) and Paris saponin II (PSII) (formosanin C) in cancer treatments have not yet been fully explored. Recent st...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3836

    authors: Yang M,Zou J,Zhu H,Liu S,Wang H,Bai P,Xiao X

    更新日期:2015-05-01 00:00:00

  • Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.

    abstract::Mast cell-derived chymase promotes inflammatory responses and tissue fibrosis. Although previous studies have reported changes in the number of mucosal mast cells in inflammatory bowel disease (IBD), the behaviour of chymase immunopositive mast cells has not been studied. In this study, we immunohistochemically invest...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Andoh A,Deguchi Y,Inatomi O,Yagi Y,Bamba S,Tsujikawa T,Fujiyama Y

    更新日期:2006-07-01 00:00:00

  • A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.

    abstract::The aim of the present study was to investigate the efficacy of using human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) as gene delivery vectors in the treatment of ovarian cancer. Lentivectors overexpressing cytosine deaminase (CD) and herpes simplex virus thymidine kinase (HSV-tk) (pGC-FU-CD-TK) ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2898

    authors: Jiang J,Wei D,Sun L,Wang Y,Wu X,Li Y,Fang Z,Shang H,Wei Z

    更新日期:2014-02-01 00:00:00

  • Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages.

    abstract::In this study 10(7) peripheral blood mononuclear cells including on average 78.56% CD19+/CD5+ lymphocytes were irradiated, and then administered intradermally as an anti-cancer vaccine to seventeen patients with B-cell chronic lymphocytic leukemia (B-CLL) at early stages (twelve injections, four at a weekly interval f...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Hus I,Kawiak J,Tabarkiewicz J,Radej S,Hoser G,Bojarska-Junak A,Schmitt M,Giannopoulos K,Dmoszynska A,Rolinski J

    更新日期:2008-08-01 00:00:00

  • miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.

    abstract::Forkhead box F2 transcription factor (FoxF2) has been described to promote organ development, extracellular matrix (ECM) synthesis and epithelial-mesenchymal interaction. Although recent studies reported decreased FoxF2 expression in several types of cancers, indicating its potential role in carcinogenesis, the mechan...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3833

    authors: Zhang Y,Wang X,Wang Z,Tang H,Fan H,Guo Q

    更新日期:2015-05-01 00:00:00

  • Expression of cyclin B1, D1 and K in non‑small cell lung cancer H1299 cells following treatment with sulforaphane.

    abstract::Sulforaphane (SFN) was first isolated from broccoli sprout and it is present at high concentrations in plants belonging to the Cruciferae family. The chemotherapeutic and anti‑cancerogenic capacities of SFN have been demonstrated by inhibition of cancer cell proliferation in several cancer cell lines. The aim of the p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6919

    authors: Żuryń A,Krajewski A,Klimaszewska-Wiśniewska A,Grzanka A,Grzanka D

    更新日期:2019-02-01 00:00:00

  • Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.

    abstract::The clinical significance of NK-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia (CLL) is still a subject of controversy. There are few previous descriptions that this cell population can be qualitatively or quantitatively deficient in CLL patients. In the present study we investigated the clinical value o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000924

    authors: Bojarska-Junak A,Hus I,Sieklucka M,Wasik-Szczepanek E,Mazurkiewicz T,Polak P,Dmoszynska A,Rolinski J

    更新日期:2010-09-01 00:00:00

  • Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins.

    abstract::MAP kinase signaling proteins have major implications in the molecular oncogenesis of breast cancers and have been extensively investigated as putative targets for therapy. This study reports the investigation of the expression of P38 MAPK and its phosphorylated form (p-P38 MAPK) in clinical specimens of invasive brea...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2645

    authors: Merlin JL,Harlé A,Lion M,Ramacci C,Leroux A

    更新日期:2013-10-01 00:00:00

  • Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).

    abstract::Hepatocellular carcinoma (HCC) is one of the most common tumors in the world. At present, the details of the mechanism responsible for HCC formation and maintenance remain unclear. However, the cancer stem cell (CSC) theory suggests that liver cancer stem cells (LCSCs) may be respon...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2012.2082

    authors: Song K,Wu J,Jiang C

    更新日期:2013-01-01 00:00:00

  • Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.

    abstract::Paired box 6 (PAX6) is a transcription factor that has oncogenic features. In breast cancer, PAX6 facilitates tumor progression; however, the underlying mechanism is largely unknown. The majority of breast cancer‑related mortalities are associated with metastasis of cancer cells. Therefore, the present study aimed to ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7644

    authors: Jin M,Gao D,Wang R,Sik A,Liu K

    更新日期:2020-08-01 00:00:00

  • MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.

    abstract::Breast cancer is the most common cancer type and the leading cause of cancer‑associated mortality in women across the majority of countries. In general, the incidence of breast cancer has been decreasing in developed countries over the previous 20 years, while it has increased in the other areas, such as the Asian‑Pac...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7549

    authors: Han R,Zhao J,Lu L

    更新日期:2020-06-01 00:00:00

  • Actin disruption agents induce phosphorylation of histone H2AX in human breast adenocarcinoma MCF-7 cells.

    abstract::Modified actin dynamics are a unique feature of transformed cancer cells and thereby promising targets for cancer chemotherapy. While latrunculin B (LB) and pectenotoxin-2 (PTX-2), both derived from natural sources, inhibit actin polymerization, jasplakinolide (JSP) prevents actin depolymerization. The purpose of this...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1214

    authors: Shin IJ,Ahn YT,Kim Y,Kim JM,An WG

    更新日期:2011-05-01 00:00:00

  • Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.

    abstract::Somatic mitochondrial DNA (mtDNA) mutations have been found in a subset of endometrial cancers (EC) from different populations. We have investigated the relationship between mtDNA changes and clinical and pathological variables of women affected by EC. mtDNA mutations were detected both in early (3/32; 9%) and in adva...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Semczuk A,Lorenc A,Putowski L,Futyma K,Bryk J,Miotla P,Bartnik E

    更新日期:2006-11-01 00:00:00

  • High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H.

    abstract::The TP53 mutation (R175H) is one of the most common mutations in human cancer. It is a highly attractive strategy for cancer therapy to find the genes that lead the R175H-expressing cancer cells. The aim of this study was to identify the synthetic sick/lethal gene interacting with R175H. Using lentiviral bar-coded com...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2953

    authors: Imai H,Kato S,Sakamoto Y,Kakudo Y,Shimodaira H,Ishioka C

    更新日期:2014-03-01 00:00:00